TaiMed Biologics (4147) — Financial Flexibility Index
TaiMed Biologics (4147) has a Financial Flexibility Index of 0.04x as of December 2025. Free cash flow of NT$42.70 Million (operating CF NT$25.95 Million minus capex NT$16.75 Million) represents 0% of total liabilities (NT$953.05 Million). Also explore net asset growth rate of TaiMed Biologics to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
TaiMed Biologics Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for TaiMed Biologics across 11 annual periods. Check 4147 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for TaiMed Biologics (2015–2025)
Year-by-year free cash flow to debt coverage for TaiMed Biologics. For the full company profile including market capitalisation, see 4147 market cap overview.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.22x | NT$213.91 Million | NT$191.14 Million | NT$953.05 Million | ▲ +160.8% |
| 2024 | -0.37x | NT$-360.20 Million | NT$-379.55 Million | NT$976.34 Million | ▼ -2418.8% |
| 2023 | -0.01x | NT$-19.45 Million | NT$-25.60 Million | NT$1.33 Billion | ▲ +96.6% |
| 2022 | -0.43x | NT$-601.65 Million | NT$-605.21 Million | NT$1.39 Billion | ▼ -259.4% |
| 2021 | -0.12x | NT$-201.59 Million | NT$-211.28 Million | NT$1.67 Billion | ▼ -45.0% |
| 2020 | -0.08x | NT$-148.32 Million | NT$-201.94 Million | NT$1.78 Billion | ▲ +82.1% |
| 2019 | -0.47x | NT$-533.77 Million | NT$-655.31 Million | NT$1.14 Billion | ▼ -202.4% |
| 2018 | 0.46x | NT$323.53 Million | NT$-522.86 Million | NT$710.55 Million | ▲ +140.2% |
| 2017 | -1.13x | NT$-238.37 Million | NT$-516.48 Million | NT$210.71 Million | ▲ +38.7% |
| 2016 | -1.84x | NT$-162.31 Million | NT$-172.29 Million | NT$87.99 Million | ▲ +88.9% |
| 2015 | -16.64x | NT$-443.05 Million | NT$-446.26 Million | NT$26.63 Million | — |